Your session is about to expire
← Back to Search
Study Summary
This trial will test whether eating whole salmon, which is rich in the bioactive compound astaxanthin, can help to reduce inflammation in obese prediabetic individuals. The investigators hope that this will lead to improved metabolic outcomes in obesity and type 2 diabetes.
- Inflammation
- Gut Microbiome
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
What is the enrollment number for this scientific research?
"Indeed, records from clinicaltrials.gov indicate that this trial is currently accepting participants. It was first made visible on August 1st 2021 and then revised most recently on August 9th 2022. At the moment, 30 subjects are being accepted at one site of participation."
Is there an opportunity for new participants to join this experiment?
"Affirmative. The clinicaltrials.gov website confirms that this medical exploration is actively recruiting participants, having been posted on August 1st 2021 and updated more recently on August 9th 2022. Thirty people are needed to take part in the study at a single site."
Does this trial accommodate those aged 85 and above?
"As indicated in the study's enrollment guidelines, eligible participants must be between 30 and 50 years old."
Who is eligible to become a participant in this research endeavor?
"To meet the criteria for this medical trial, individuals must possess inflammation and be between 30 to 50 years old. The research team aims to enroll approximately 30 participants."
Share this study with friends
Copy Link
Messenger